Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Reality Check
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Marathon11on May 17, 2019 3:59pm
166 Views
Post# 29756992

RE:RE:RE:RE:RE:Reality Check

RE:RE:RE:RE:RE:Reality CheckCan't disagree with any of that. Weak sense of urgency and track record of missed milestones and inability to drive shareholder value. I am hopeful that Jesse and the new Chair of the BOD can change the game in conjunction with this major acquisition. Hopefully the rest of the BOD will be changed out sooner rather than later. They need institutional coverage... essentially they have none as I don't really count BB. Will see if Deerfield will be an enabler of growth and success or not. Pathetic that they don't have Resultz US partnership as a milestone in 2019... another example of weak sense of urgency. All my opinion... I still believe this portfolio is worth multiples of where the sp is today. Will see... I ain't selling, and will continue to nibble.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities